APC anti-mouse F4/80 Antibody

Pricing & Availability
Clone
BM8 (See other available formats)
Regulatory Status
RUO
Other Names
EMR1, Ly71
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
BM8_APC_122007
Thioglycolate-elicited BALB/c mouse peritoneal macrophages stained with BM8 APC
  • BM8_APC_122007
    Thioglycolate-elicited BALB/c mouse peritoneal macrophages stained with BM8 APC
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
123115 25 µg 40€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
123116 100 µg 115€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

F4/80 is a 160 kD glycoprotein. It is characterized as a member of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80, also known as EMR1 or Ly71, has been widely used as a murine macrophage marker, which is expressed on the majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen (but not on the macrophages located in T cell areas of the spleen, lymph node and Peyer's patch), Kuffer cells, Langerhans cells, and bone marrow stromal cells. F4/80 has also been shown on a subset of dendritic cells. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for induction of CD8+ T cells-mediated peripheral tolerance.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Murine macrophages
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The F4/80 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13.

Application References

(PubMed link indicates BioLegend citation)
  1. Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC)
  2. Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC)
  3. Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed
  4. Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed
  5. Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed
  6. Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC)
  7. Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC)
  8. Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed
  9. Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed
  10. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
  11. Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Zhao Z, et al. 2021. Nat Commun. 12:4355. PubMed
  2. Marchelletta RR, et al. 2021. J Clin Invest. 131:. PubMed
  3. Nguyen T, et al. 2021. STAR Protoc. 2:101004. PubMed
  4. Grandjean CL, et al. 2021. Sci Adv. 7:. PubMed
  5. Deng R, et al. 2022. Adv Sci (Weinh). 9:e2103343. PubMed
  6. Yang D, et al. 2022. Cell. 185:1905. PubMed
  7. Zheng J, et al. 2022. Front Pharmacol. 13:866228. PubMed
  8. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  9. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  10. Huang W, et al. 2015. J Allergy Clin Immunol. . PubMed
  11. Barrett N, et al. 2016. Cell Rep. 16: 1039-1054. PubMed
  12. Liu Y, et al. 2021. Cell Metabolism. 33(6):1221-1233.e11. PubMed
  13. Ying W, et al. 2019. Cell Metab. 29:457. PubMed
  14. Saha D et al. 2017. Cancer cell. 32(2):253-267 . PubMed
  15. Yan X, et al. 2022. Commun Biol. 5:320. PubMed
  16. Li Y, et al. 2022. Int J Biol Sci. 18:3697. PubMed
  17. He R, et al. 2021. J Immunol. 206:2353. PubMed
  18. Suresh R, et al. 2020. J Immunother Cancer. 8:. PubMed
  19. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
  20. Zhang R, et al. 2021. Cell Mol Immunol. 18:1222. PubMed
  21. Kurosawa M, et al. 2021. Int J Mol Sci. 22:. PubMed
  22. He F, et al. 2021. J Exp Med. 218:. PubMed
  23. Platt DJ, et al. 2021. Cell Reports. 35(6):109113. PubMed
  24. Du J, et al. 2020. Developmental Cell. 55(6):737-753.e7. PubMed
  25. Gerwing M, et al. 2020. Mol Imaging Biol. 1.959027778. PubMed
  26. Bousset L, et al. 2020. PLoS Biol. 18:e3000948. PubMed
  27. Yu J, et al. 2020. Sci Rep. 10:21360. PubMed
  28. Sharma-Chawla N, et al. 2016. Infect Immun . . PubMed
  29. Emal D, et al. 2016. J Am Soc Nephrol. 10.1681/ASN.2016030255. PubMed
  30. Dale M, et al. 2016. J Immunol. 196: 4536 - 4543. PubMed
  31. Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
  32. Jaiswal M, et al. 2015. Sci Rep. 5: 15221. PubMed
  33. Bieren J, et al. 2015. J Immunol. 194:1154. PubMed
  34. Prantner D, et al. 2009. Infect Immun. 77:5334. PubMed
  35. Cullis J, et al. 2017. Cancer Immunol Res. 5:182. PubMed
  36. Kim SE, et al. 2019. Nutrients. 11. PubMed
  37. Chang T, et al. 2017. PLoS Pathog. 10.1371/journal.ppat.1006485. PubMed
  38. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  39. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  40. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
  41. Stubelius A, et al. 2012. Immunobiology. 217:751. PubMed
  42. Sjöstrand M, et al. 2013. J Immunol. 191:3753. PubMed
  43. Li X, et al. 2015. Proc Natl Acad Sci U S A. 112:6080. PubMed
  44. Tan X, et al. 2016. PLoS One. 11: 0160985. PubMed
  45. Yilmaz B, et al. 2021. Cell Host Microbe. 29(4):650-663.e9. PubMed
  46. Dong L, et al. 2021. Cancer Cell. . PubMed
  47. Gonçalves NP, et al. 2017. J Neuroinflammation. 14:115. PubMed
  48. Yates C, et al. 2017. Stem Cell Res Ther. 10.1186/s13287-017-0644-9. PubMed
  49. Lancaster JN, et al. 2019. Nat Commun. 10:2220. PubMed
  50. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  51. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  52. Han J, et al. 2022. FEBS J. 289:417. PubMed
  53. Zhao J, et al. 2022. J Nanobiotechnology. 20:62. PubMed
  54. Liang F, et al. 2021. Front Immunol. 12:658715. PubMed
  55. Nam J, et al. 2021. Adv Sci (Weinh). 2002577:8. PubMed
  56. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  57. Zheng H, et al. 2021. Frontiers in Cell and Developmental Biology. 9:641527. PubMed
  58. Xu Y, et al. 2020. Mol Ther. 28:202. PubMed
  59. Mia MM, et al. 2020. PLoS Biol. 18:e3000941. PubMed
  60. Xing J, et al. 2016. Nat Immunol. 17:1373-1380. PubMed
  61. Zhu J, et al. 2016. Sci Rep. 6:27136. PubMed
  62. Sun P, et al. 2015. J Hepatol. . PubMed
  63. Shen H, et al. 2015. Infect Immun . 83: 2694 - 2704. PubMed
  64. Gritsina G, et al. 2015. Mol Cancer Ther. 14:1035. PubMed
  65. Wong E, et al. 2019. Cell Rep. 29:3047. PubMed
  66. Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed
  67. Álvaro de Mingo Pulido et al. 2018. Cancer cell. 33(1):60-74 . PubMed
  68. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  69. Sun Q, et al. 2022. Cell Death Dis. 13:724. PubMed
  70. Rybalko V, et al. 2015. PLoS One. 10: 0145550. PubMed
  71. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  72. Tajfirouz D, et al. 2017. Virology. 10.1016/j.virol.2017.02.022. PubMed
  73. Krivanek J, et al. 2020. Nat Commun. 3.802777778. PubMed
  74. Brestoff JR, et al. 2021. Cell Metab. 33:270. PubMed
  75. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  76. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  77. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  78. Molina-Sanchez P, et al. 2020. Gastroenterology. 2203:159. PubMed
  79. Qi F, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.05.008. PubMed
  80. Stefan K, et al. 2017. PLoS One. . 10.1371/journal.pone.0188600. PubMed
  81. Sinha M, et al. 2018. Nat Commun. 9:936. PubMed
  82. Grohmann M et al. 2018. Cell. 175(5):1289-1306 . PubMed
  83. Kosack L, et al. 2017. Sci Rep. 7:11289. PubMed
  84. Christopher S Garris et al. 2018. Immunity. 49(6):1148-1161 . PubMed
  85. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  86. Zhong J, et al. 2018. Sci Adv. 4:eaas9864. PubMed
  87. Wang Y, et al. 2022. Front Immunol. 13:767630. PubMed
  88. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  89. Kosaric N, et al. 2020. Mol Ther. 28:2007. PubMed
  90. Ling X, et al. 2021. ACS Nano. 15:765. PubMed
  91. Gordon RA, et al. 2020. PLoS One. 15:e0226396. PubMed
  92. He C, et al. 2021. Oncoimmunology. 1897295:10. PubMed
  93. Jiao H, et al. 2021. Cell. 184(11):2896-2910.e13. PubMed
  94. Shang Y, et al. 2016. Nat Immunol. 10.1038/ni.3486. PubMed
  95. Lasky C, et al. 2015. Infect Immun . 83: 2627 - 2635. PubMed
  96. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  97. Vannini N, et al. 2019. Cell Stem Cell. 24:405. PubMed
  98. Nguyen CM, et al. 2019. Diabetes. 68:1499. PubMed
  99. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  100. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  101. Jeong SJ, et al. 2021. Autophagy. 17:3740. PubMed
  102. Guo W, et al. 2022. J Immunother Cancer. 10:. PubMed
  103. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  104. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  105. Helmi N, et al. 2015. J Infect Dis. 211:1677. PubMed
  106. Tsoyi K, et al. 2015. J Leukoc Biol. 97:171. PubMed
  107. Ma Y, et al. 2015. Cardiovasc Res. 106:421. PubMed
  108. Ben-Shaanan T, et al. 2016. Nat Med. 10.1038/nm.4133. PubMed
  109. Karki R, et al. 2020. JCI Insight. 5:00. PubMed
  110. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  111. Sun L, et al. 2020. J Immunol. 2177:204. PubMed
  112. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  113. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  114. Luan HH et al. 2019. Cell. 178(5):1231-1244 . PubMed
  115. Shimokawa C et al. 2017. Immunity. 46(5):863-874 . PubMed
  116. Giri J, et al. 2020. Cell Rep. 30:1923. PubMed
  117. Galvão I, et al. 2018. Front Immunol. 9:142. PubMed
  118. Alexander RK, et al. 2020. eLife. 9:e54090.. PubMed
  119. Prantner D, et al. 2011. Infect Immun. 79:3922. PubMed
  120. Zein HS, et al. 2022. Sci Rep. 12:4834. PubMed
  121. Luo W, et al. 2022. Front Immunol. 13:816761. PubMed
  122. Lv F, et al. 2022. iScience. 25:103639. PubMed
  123. Wu L, et al. 2022. Theranostics. 12:842. PubMed
  124. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  125. Jiao Y, et al. 2021. Crit Care. 25:356. PubMed
  126. Gao H, et al. 2021. Cells. 10:. PubMed
  127. Carozza JA, et al. 2020. Nat Cancer. 184:1. PubMed
  128. Agrawal V, et al. 2016. J Leukoc Biol. 100: 261 - 274. PubMed
  129. Amash A, et al. 2016. J Immunol. 196: 3331-3340. PubMed
  130. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  131. Sullivan B, et al. 2015. PLoS Pathog. 11:1004588. PubMed
  132. Oatley J, et al. 2009. Development. 136:1191. PubMed
  133. Frazier T, et al. 2018. Adipocyte. 0.41875. PubMed
  134. An W et al. 2019. British journal of pharmacology. 176(5):699-710 . PubMed
  135. Yu Y, et al. 2019. J Clin Invest. 129:546. PubMed
  136. Linde N, et al. 2018. Nat Commun. 9:21. PubMed
  137. Anstine L,et al. 2017. J Am Heart Assoc.. 10.1161/JAHA.117.007097. PubMed
  138. Mao FY, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:395. PubMed
  139. Shi R, et al. 2022. Theranostics. 12:875. PubMed
  140. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  141. Glauser D, et al. 2013. J Virol. 87:10828. PubMed
  142. Bretscher P, et al. 2015. EMBO Mol Med. 7:593. PubMed
  143. Hara-Chikuma H 2016. Mol Cell Biol. 36: 1206-1218. PubMed
  144. Hu J, et al. 2020. Theranostics. 7.154166667. PubMed
  145. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  146. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  147. Chen F et al. 2018. Cell reports. 25(10):2775-2783 . PubMed
  148. Liao T, et al. 2017. Front Immunol. 8:1334. PubMed
  149. Deng M, et al. 2020. Nat Commun. 11:2193. PubMed
  150. Pinho S, et al. 2022. Nat Cell Biol. 24:290. PubMed
  151. Lin S, et al. 2022. Nat Commun. 13:3301. PubMed
  152. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  153. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  154. Tartey S, et al. 2021. Cancer Research. 81(9):2358-2372. PubMed
  155. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  156. Wang W, et al. 2018. Oncogenesis. 7:97. PubMed
  157. Xie Z, et al. 2018. J Am Heart Assoc. 7:e007442. PubMed
  158. Pfefferlé M, et al. 2021. Front Immunol. 12:680855. PubMed
  159. Wara AK, et al. 2020. Cell Rep. 33:108550. PubMed
  160. Fu Z, et al. 2021. Cell Res. 31:631. PubMed
  161. Yang Y, et al. 2022. Elife. 11:. PubMed
  162. Fairfax K, et al. 2013. J Immunol. 191:4202. PubMed
  163. Ericson J, et al. 2014. PLoS One. 9:108553. PubMed
  164. Toda G, et al. 2021. STAR Protoc. 2:100246. PubMed
  165. Guldner IH, et al. 2020. Cell. 183(5):1234-1248.e25. PubMed
  166. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  167. Fraccarollo D, et al. 2021. eLife. 0.416666666666667. PubMed
  168. Wang T, et al. 2018. Front Physiol. 9:209. PubMed
  169. Xiang W, et al. 2018. Nat Commun. 9:2574. PubMed
  170. Moon HG et al. 2018. Immunity. 49(2):275-287 . PubMed
  171. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  172. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  173. Matundan H, et al. 2019. J Virol. 93. PubMed
  174. Yu L, et al. 2019. Elife. 8:e46677. PubMed
  175. Ruiz de Azua I, et al. 2017. J Clin Invest. 127:4148. PubMed
  176. Li Y, et al. 2020. Cell Reports. 27(10):2809-2816.e3.. PubMed
  177. Chung EJ, et al. 2022. Aging (Albany NY). 14:7692. PubMed
  178. Puigdelloses M, et al. 2021. J Immunother Cancer. 9:. PubMed
  179. Lang V, et al. 2021. Elife. 10:. PubMed
  180. Jaggi U, et al. 2021. PLoS Pathog. 17:e1009999. PubMed
  181. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  182. Tapia-Abellán A, et al. 2021. Sci Adv. 7:eabf4468. PubMed
  183. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  184. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  185. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  186. Dewi IMW, et al. 2021. Cell Reports Medicine. 2(5):100289. PubMed
  187. Oguri Y, et al. 2020. Cell. 182(3):563-577.e20. PubMed
  188. Ni J, et al. 2020. Immunity. 52(6):1075-1087.e8. PubMed
  189. Madenspacher JH, et al. 2020. JCI Insight. 5:00. PubMed
  190. Kostadinova E, et al. 2016. Sci Rep. 6:30943. PubMed
  191. Tan X, et al. 2015. Sci Rep. 5: 15702. PubMed
  192. Kuwahara G, et al. 2014. PLoS One. 9:106987. PubMed
  193. Patankar Y, et al. 2013. Infect Immun . 81:2043. PubMed
  194. Kyburz A, et al. 2019. J Allergy Clin Immunol. 143:1496. PubMed
  195. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  196. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  197. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  198. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  199. Brown SM et al. 2017. Endocrinology. 158(10):3592-3604 . PubMed
  200. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  201. Zheng X, et al. 2018. J Clin Invest. 128:2104. PubMed
  202. Ye ZH, et al. 2021. Transl Oncol. 14:101162. PubMed
  203. Ito T, et al. 2021. Nat Commun. 12:2232. PubMed
  204. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  205. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  206. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  207. Yu W, et al. 2022. Nat Commun. 13:3544. PubMed
  208. Li Q, et al. 2022. Front Cardiovasc Med. 9:872102. PubMed
  209. Pandit M, et al. 2021. Eur J Immunol. 51:1461. PubMed
  210. Li D, et al. 2022. Emerg Microbes Infect. 11:2248. PubMed
  211. Kim K, et al. 2014. Proc Natl Acad Sci U S A. 111:11774. PubMed
  212. Hu J, et al. 2015. J Hepatol. Available online 31 August 2015. PubMed
  213. Terrazas M 2014. Int J Parasit. 44 613 . PubMed
  214. Yang C, et al. 2016. Sci Rep. 6:34643. PubMed
  215. Jiang Q, et al. 2020. JCI Insight. 5:00. PubMed
  216. Kesavardhana S, et al. 2020. J Biol Chem. 295:8325. PubMed
  217. Cao Q, et al. 2019. Theranostics. 5.576388889. PubMed
  218. Pascual-Pasto G, et al. 2022. J Immunother Cancer. 10:. PubMed
  219. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  220. Chen F, et al. 2022. Cell Rep. 38:110215. PubMed
  221. Wang S, et al. 2021. Commun Biol. 22:. PubMed
  222. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  223. Calle P, et al. 2021. Cells. 10:. PubMed
  224. Ishikura S, et al. 2021. J Cell Biochem. . PubMed
  225. Wang G, et al. 2021. Cell Host Microbe. 29(5):777-791.e6. PubMed
  226. Desai P, et al. 2021. Cell. 184(5):1214-1231.e16. PubMed
  227. Chen Z, et al. 2016. Nat Commun. 7:11596. PubMed
  228. Deng W, et al. 2015. Clin Immunol. . PubMed
  229. Honda H, et al. 2014. J Leukoc Biol. 96:1087. PubMed
  230. Shaw O, et al. 2014. Rheumatology. 53:1901. PubMed
  231. Rosenbaum SR, et al. 2020. Cell Rep. 30:510. PubMed
  232. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  233. Petkevicius K, et al. 2019. Elife. 8:e47990. PubMed
  234. Cianciaruso C, et al. 2020. Cell Reports. 27(10):3062-3080.e11.. PubMed
  235. Engblom C, et al. 2017. Science. 358:6367. PubMed
  236. Zhao F et al. 2018. Immunity. 48(1):147-160 . PubMed
  237. Lima-Junior D, et al. 2017. J Immunol. 10.4049/jimmunol.1700258. PubMed
  238. Hua X, et al. 2021. Front Immunol. 12:706027. PubMed
  239. Liu J, et al. 2021. Front Immunol. 12:733808. PubMed
  240. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  241. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  242. Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
  243. Horsle B 2013. Development. 140:1517. PubMed
  244. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  245. Ding H, et al. 2016. Nat Commun. 7:11533. PubMed
  246. Gamradt P, et al. 2016. PLoS Pathog. 12:e1006032. PubMed
  247. Wang X, et al. 2016. J Immunol. 197(12):4750-4761. PubMed
  248. Zhang H, et al. 2017. Immunol Cell Biol. 10.1038/icb.2017.11. PubMed
  249. Tian Y, et al. 2020. JCI Insight. 5:00. PubMed
  250. Kerkhofs D, et al. 2020. Theranostics. 7.022222222. PubMed
  251. Toda G, et al. 2020. Molecular Cell. 79(1):43-53.e4. PubMed
  252. Karki R, et al. 2020. bioRxiv. . PubMed
  253. Di Genua C, et al. 2019. Haematologica. 104:2215. PubMed
  254. Zhu K, et al. 2022. EMBO Rep. 23:e54499. PubMed
  255. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  256. Liu R, et al. 2020. Eur J Vasc Endovasc Surg. 60:254. PubMed
  257. Zhang W, et al. 2021. Front Immunol. 12:768435. PubMed
  258. Panagi M, et al. 2020. Theranostics. 10:1910. PubMed
  259. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  260. Gu H, et al. 2021. Elife. 10:. PubMed
  261. Nishio H, et al. 2020. Regen Ther. 14:262. PubMed
  262. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  263. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  264. Karki R, et al. 2021. Cell. 184:149. PubMed
  265. Caoa X, et al. 2017. Neurosci Lett. 10.1016/j.neulet.2017.02.045. PubMed
  266. Jeurissen M, et al. 2016. PLoS One. 11:e0167199. PubMed
  267. Montero-Barrera D, et al. 2015. BioMed Res Int. 2015 615865. PubMed
  268. Neimert-Andersson T, et al. 2011. Vaccine. 29:8965. PubMed
  269. Sun L, et al. 2009. FASEB J. 3.602777778. PubMed
  270. Esposito E, et al. 2019. Nat Commun. 4.101388889. PubMed
  271. Ji L et al. 2019. Immunity. 51(2):272-284 . PubMed
  272. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  273. Zhang A, et al. 2021. Theranostics. 11:3839. PubMed
  274. Adzika GK, et al. 2021. Front Cell Dev Biol. 9:719351. PubMed
  275. Mirsoian A, et al. 2014. J Exp Med. 211:2373. PubMed
  276. Yin X, et al. 2015. J Immunol. 194:4029. PubMed
  277. Kuo P, et al. 2016. J Am Heart Assoc. 5: 002610. PubMed
  278. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  279. Wang Z et al. 2019. Cell reports. 26(5):1273-1285 . PubMed
  280. Nishino T, et al. 2018. Arterioscler Thromb Vasc Biol. 38:2460. PubMed
  281. Meng Michelle Xu et al. 2017. Immunity. 47(2):363-373 . PubMed
  282. Singh KS, et al. 2020. Nat Commun. 0.786805556. PubMed
  283. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  284. Chan JY, et al. 2019. Diabetologia. 62:993. PubMed
  285. Ling X, et al. 2021. Biomaterials. 270:120690. PubMed
  286. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  287. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  288. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  289. Teng F, et al. 2021. Cell Rep. 37:110051. PubMed
  290. Adzika GK, et al. 2021. Front Cardiovasc Med. 8:719805. PubMed
  291. Wang X, et al. 2021. Theranostics. 11:209. PubMed
  292. Liu SS, et al. 2021. Immunity. :. PubMed
  293. Freed-Pastor WA, et al. 2021. Cancer Cell. :. PubMed
  294. Cao H, et al. 2020. Front Pharmacol. 11:578943. PubMed
  295. Ngkelo A, et al. 2016. J Exp Med. 213: 1353 - 1374. PubMed
  296. Sockolosky J, et al. 2016. Proc Natl Acad Sci U S A. 113: 2646 - 2654. PubMed
  297. Wan X, Thomas J, Unanue E 2016. J Exp Med. 213: 967 - 978. PubMed
  298. Ishizuka M, et al. 2015. PLoS One. 10: 0137978. PubMed
  299. Pechous R, et al. 2015. MBio. 6:2302. PubMed
  300. Yin T, et al. 2015. J Immunol. 194:429. PubMed
  301. Klezovich-Bénard M, et al. 2012. PLoS One. 8:e1002481. PubMed
  302. Karpurapu M, et al. 2011. Blood. 118:5255. PubMed
  303. Yan K, et al. 2020. Cell Death Dis. 1.013888889. PubMed
  304. Eghbalzadeh K, et al. 2019. Front Immunol. 2.022916667. PubMed
  305. Ouadah Y, et al. 2019. Cell. 179:403. PubMed
  306. Gardner A, et al. 2022. J Immunother Cancer. 10:. PubMed
  307. Tang L, et al. 2022. Front Immunol. 12:770402. PubMed
  308. Caporarello N, et al. 2022. Nat Commun. 13:4170. PubMed
  309. Collins C, et al. 2014. Proc Natl Acad Sci U S A. 111:9899. PubMed
  310. Bramwell K, et al. 2015. J Immunol. 195: 1647 - 1656. PubMed
  311. Legrain S, et al. 2015. J Immunol. 195: 4171 - 4175. PubMed
  312. Schuijs M, et al. 2016. PLoS One. 11: 016188. PubMed
  313. Lerbs T, et al. 2020. JCI Insight. 5:00. PubMed
  314. Wang J, et al. 2020. Cell. 183(7):1867-1883.e26. PubMed
  315. Wu L, et al. 2020. Cancer Immunol Res. 710:8. PubMed
  316. Fu W, et al. 2020. J Immunol Res. 8820355:2020. PubMed
  317. Saul S, et al. 2019. J Leukoc Biol. N/A. PubMed
  318. Koupenova M, et al. 2019. iScience. 19:916. PubMed
  319. Yuan Y, et al. 2019. Clin Sci (Lond). 133:1759. PubMed
  320. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  321. Boguslawski KM, et al. 2020. Sci Adv. 6:eaax7515. PubMed
  322. Kim M, et al. 2012. J Immunol. 188:4158. PubMed
  323. Fearon AE, et al. 2021. iScience. 24:103143. PubMed
  324. Chung EJ, et al. 2021. Int J Radiat Oncol Biol Phys. 110:526. PubMed
  325. Murray CW, et al. 2022. Nat Commun. 13:1090. PubMed
  326. Qu J, et al. 2021. Int J Biol Sci. 17:2756. PubMed
  327. Liu ZZ, et al. 2021. Front Immunol. 12:636861. PubMed
  328. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  329. Kapralov AA, et al. 2020. Nat Chem Biol. 278:16. PubMed
  330. Xiang W, et al. 2020. Signal Transduct Target Ther. 0.374305556. PubMed
  331. Badgujar DC, et al. 2020. PLoS Pathog. 16:e1009016. PubMed
  332. Steinmetz O, et al. 2016. J Infect Dis. 10.1093/infdis/jiv763. PubMed
  333. Malik M, et al. 2012. Proc Natl Acad Sci U S A. 109:6130. PubMed
  334. Kim SH, et al. 2020. Neoplasia. 1.3375. PubMed
  335. Maas SLN, et al. 2020. J Neuroinflammation. 17:120. PubMed
  336. Thomson CA, et al. 2018. J Immunol. 201:215. PubMed
  337. Sparber F et al. 2019. British journal of pharmacology. 176(11):1728-1744 . PubMed
  338. Lalor R, et al. 2019. Nutrients. 11. PubMed
RRID
AB_893493 (BioLegend Cat. No. 123115)
AB_893481 (BioLegend Cat. No. 123116)

Antigen Details

Structure
EGF-TM7 family member, 160 kD glycoprotein
Distribution

Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kuffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells

Function
Induction of immunological tolerance
Cell Type
Dendritic cells, Langerhans cells, Macrophages, Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Antigen References

1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805.
2. Hume DA, et al. 1983. J. Exp. Med. 158:1522.
3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801.
4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486.
5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.

Gene ID
13733 View all products for this Gene ID
UniProt
View information about F4/80 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 10/25/2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Brilliant Violet 605™ anti-mouse F4/80

  • Purified anti-mouse F4/80

  • Biotin anti-mouse F4/80

  • FITC anti-mouse F4/80

  • PE anti-mouse F4/80

  • PE/Cyanine5 anti-mouse F4/80

  • PE/Cyanine7 anti-mouse F4/80

  • APC anti-mouse F4/80

  • APC/Cyanine7 anti-mouse F4/80

  • Alexa Fluor® 488 anti-mouse F4/80

  • Alexa Fluor® 647 anti-mouse F4/80

  • Pacific Blue™ anti-mouse F4/80

  • PerCP anti-mouse F4/80

  • PerCP/Cyanine5.5 anti-mouse F4/80

  • Alexa Fluor® 700 anti-mouse F4/80

  • Brilliant Violet 421™ anti-mouse F4/80

  • Brilliant Violet 510™ anti-mouse F4/80

  • Alexa Fluor® 594 anti-mouse F4/80

  • Brilliant Violet 785™ anti-mouse F4/80

  • Purified anti-mouse F4/80 (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse F4/80

  • Brilliant Violet 650™ anti-mouse F4/80

  • Brilliant Violet 711™ anti-mouse F4/80

  • APC/Fire™ 750 anti-mouse F4/80

  • TotalSeq™-A0114 anti-mouse F4/80

  • TotalSeq™-B0114 anti-mouse F4/80

  • TotalSeq™-C0114 anti-mouse F4/80

  • Spark YG™ 570 anti-mouse F4/80

  • KIRAVIA Blue 520™ anti-mouse F4/80

  • Ultra-LEAF™ Purified anti-mouse F4/80

  • APC/Fire™ 810 anti-mouse F4/80

  • Spark NIR™ 685 anti-mouse F4/80

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account